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A B S T R A C T
Introduction: Despite the growing interest in the study of Gram-negative bacilli (GNB) 
infections, very little information on osteomyelitis caused by GNB is available in the 
medical literature. 
Objectives and methods: To assess clinical and microbiological features of 101 cases of 
osteomyelitis caused by GNB alone, between January 2007 and January 2009, in a reference 
center for the treatment of high complexity traumas in the city of São Paulo. 
Results: Most patients were men (63%), with median age of 42 years, affected by chronic 
osteomyelitis (43%) or acute osteomyelitis associated to open fractures (32%), the majority 
on the lower limbs (71%). The patients were treated with antibiotics as inpatients for 40 
days (median) and for 99 days (median) in outpatient settings. After 6 months follow-up, the 
clinical remission rate was around 60%, relapse 19%, amputation 7%, and death 5%. Nine 
percent of cases were lost to follow-up. A total of 121 GNB was isolated from 101 clinical 
samples. The most frequently isolated pathogens were Enterobacter sp. (25%), Acinetobacter 
baumannii (21%) e Pseudomonas aeruginosa (20%). Susceptibility to carbapenems was about 
100% for Enterobacter sp., 75% for Pseudomonas aeruginosa and 60% for Acinetobacter baumannii. 
Conclusion: Osteomyelitis caused by GNB remains a serious therapeutic challenge, especially 
when associated to nonfermenting bacteria. We emphasize the need to consider these 
agents in diagnosed cases of osteomyelitis, so that an ideal antimicrobial treatment can be 
administered since the very beginning of the therapy.
© 2012 Elsevier Editora Ltda. All rights reserved.
Introduction
Osteomyelitis is even today one of the most challenging bone 
and joint infections, although the disease first descriptions 
go back to the Hippocrates era.1 Gram-positive (GP) bacteria, 
especially Staphylococcus, classically cause this disease, but 
Gram-negative bacteria have grown in importance as causative 
agents.2,3 Such importance can be explained by the increasing 
number of orthopedic surgeries with the use of implants 
and, especially, the rising number of high-energy trau- 
mas associated with open fractures, as a consequence of traffic 
accidents and war injuries.4-6
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Although Gram-negative bacilli (GNB) represent a 
minor portion of all the pathological agents isolated in 
osteomyelitis cases, they are of major clinical importance 
due to the peculiarities of their antimicrobials susceptibility 
pattern and due to the co-morbidities generally affecting 
those patients.4,7 The importance of multidrug resistant 
GNB was described more recently, as being causative 
agents of acute post-traumatic osteomyelitis among US 
military personnel with open fractures of the lower limbs, 
especially nonfermenting GNB.5
Currently there is insufficient information in the literature 
to draw any conclusion with regard to the variables involving 
osteomyelitis caused by these agents. The objective of 
this study was to describe clinical and microbiologic 
characteristics of acute and chronic osteomyelitis episodes, 
treated in a university hospital providing care for high 
complexity orthopedics cases in the city of São Paulo. 
Methods
Study design
For this retrospective analysis, our study included all patients 
with a diagnosis of osteomyelitis who were treated at our 
institution from January 2007 to January 2009. Cases whose 
bone or bone marrow aspirate cultures grew GNB were 
included. Only the first positive culture for each identified 
patient was considered. Patients exhibiting GP growth 
together with GNB and patients with contaminated cultures 
were excluded.
A total of 173 bone samples yielding positive culture 
growth for any GNB were identified. After checking 
the culture results, 51 patients were excluded due to a 
concomitant growth of at least one GP agent. Out of the 
122 remaining patients, 12 were excluded as the first 
positive culture occurred outside the study period and 9 
were excluded for exhibiting positive cultures considered 
as contamination. Data of 101 patients who fulfilled the 
inclusion criteria were reviewed.
Five clinical outcomes were analyzed six months after 
hospital discharge: disease remission, amputation of the 
affected limb, infection relapse, death and loss to follow-up.
Definitions
A culture sample was considered contamination when 
collected in the first debridement of an open fracture. 
Remission was defined as the absence of clinical signs 
and symptoms of infection, X-rays without signs of 
o s t e o m y e l i t i s ,  a n d ,  w h e n e v e r  p o s s i b l e ,  n o r m a l 
inflammatory markers. Infection relapse was defined as 
the return of signs or symptoms within six months from 
hospital discharge. Those cases with no observations 
reported in the patient chart after six months were 
considered lost to follow-up.
Symptoms of infection at presentation were divided into 
four groups: local pain, hyperemia, sinus tract formation, or 
a radiograph showing loosening of the prosthesis.
We classified osteomyelitis as hematogenous or 
contiguous, depending on the bone infection mechanism, 
and as acute or chronic, according to the onset of 
symptoms.8-10 In this study, contiguous osteomyelitis has 
been divided into post-operative osteomyelitis or open-
fracture associated osteomyelitis.
Culture samples
All bones samples were collected in the surgical center after 
extensive debridement. Samples were sent to the microbiology 
laboratory in bottles containing thioglycolate growth medium. 
Susceptibility tests were performed in most cases using the 
disk-diffusion technique; when required, minimum inhibitory 
concentrations were obtained using automatic methods or 
“e-test”, and reported in accordance with the CLSI criteria in 
force at that time.11
Statistical analysis
An essentially descriptive statistical analysis was performed. 
Frequency and percentage were used for the categorical 
and ordinal variables. Mean, median, range (minimum and 
maximum values) and standard deviation (SD) were used for 
the continuous variables. All the analyses were performed 
using software SAS® 9.1.3 and Microsoft Excel® 2007.
Results
Population data
Collected data are summarized in Table 1. Patients 
were mostly men (63.4%), median age of 42 years and 
with infection in the lower limbs (71%). Osteomyelitis 
classification was mainly chronic (43%) and associated to 
open-fractures (32%). The median days of hospital stay 
was 41 days and the major presentation of infection was a 
discharging sinus.
Outcomes and surgical procedures
After hospital discharge, outcomes were analyzed after six 
months follow-up, as shown in Table 2. The extension of 
antimicrobial treatment and the number of surgical procedures 
required for infection treatment are reported in Table 3.
Microbiology
All infectious agents found in bone cultures are shown in 
Table 4. A total of 121 agents were found in 101 bone samples, 
with a high proportion of nonfermenting GNB. Figs. 1, 2, and 3 
illustrate the susceptibility profile to antimicrobials for the 3 
most frequently isolated pathogens.
We found a low prevalence of co-morbidities and risk 
factors for infections in this population. Seventeen patients 
(17%) were smokers, eight (8%) had diabetes mellitus, three 
(3%) were illicit drug users, and one (1%) was diagnosed with 
neoplasia. No patient was diagnosed with HIV infection.
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Outcomes after 6 months follow-up n (%)
Disease clinical remission 61 (60.4%)
Relapse 19 (18.8%)
Loss to follow-up 9 (8.9%)
Amputation 7 (6.9%)
Death 5 (5%)
Total 101 (100%)
 n (%)
Days of inpatient antimicrobial treatment
 Mean (SD) 44.69 (35.52)
 Median 40
 Range 1-176
Days of outpatient antimicrobial treatment
 Mean (SD) 82.97 (61.81)
 Median 99
 Range 4-180
Number of surgical procedures
 Mean (SD) 3.41 (3.03)
 Median 2
 Range 1-13
 n (%)
Age
 Mean (SD) 44.34 (19.37)
 Median 42
Age group
 0 to 20 years 8 (7.9%)
 21 to 40 years 40 (39.6%)
 41 to 60 years 29 (28.7%)
 Over 60 years 24 (23.8%)
Gender
 Male 64 (63.4%)
 Female 37 (36.6%)
Affected segment
 Leg 31 (30.7%)
 Thigh 28 (27.7%)
 Hip 14 (13.9%)
 Foot and ankle 13 (12.9%)
 Spine 7 (6.9%)
 Hand and wrist 6 (5.9%)
 Arm 2 (2%)
 Forearm 0 (0%)
Time with symptoms – days
 Median 65
Length of hospital stay – days
 Median 41
 Acute hematogenous 0 (0%)
 Acute open fracture related 33 (32.7%)
 Chronic 44 (43.6%)
 Acute post-operative 24 (23.8%)
Presentation of infection
 Discharging sinus 70 (69.3%)
 Local pain 20 (19.8%)
 Hyperemia 7 (6.9%)
 Functional disability 4 (4%)
Table 2 - Outcomes after 6 months of follow-up
Table 3 - Extent of antimicrobial use and number of 
surgical procedures
 Pathogens isolated n (%)
Enterobacter sp. 30 (24.7%)
Acinetobacter baumannii 26 (21.4%)
Pseudomonas aeruginosa 24 (19.8%)
Klebsiella pneumoniae 10 (8.2%)
Serratia marcescens 8 (6.6%)
Proteus mirabilis 7 (5.7%)
Escherichia coli 6 (4.9%)
Providencia stuarti 3 (2.4%)
Morganella morganii 3 (2.4%)
Stenotrophomonas maltophilia 2 (1.6%)
Leclercia adecarboxylata 1 (0.8%)
Pantoea agglomerans 1 (0.8%)
Total 121
Table 4 – Pathogens isolated from bone samples
Table 1 - Characteristics of 101 patients with GNB 
osteomyelitis
Discussion
There has been an increasing amount of literature on GNB 
infection in recent years, mainly due to the difficulties 
of treating such infections. Such difficulties results from 
expression and transmission of genes tied to antimicrobial 
resistance, which reduces global efficacy of antibiotics. GNB, 
which are especially important in nosocomial infections, 
frequently exhibit resistance to multiple antibiotic classes.3
Very few follow-up studies of patients with specific GNB 
osteomyelitis diagnostic are available in the literature. 
Although some studies have assessed risk factors for the 
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Fig. 1 - Susceptibility profile of Enterobacter sp.
Fig. 2 - Susceptibility profile of Acinetobacter baumannii.
Fig. 3 - Susceptibility profile of Pseudomonas aeruginosa.
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development of prosthetic joint infections,12,13 there is no 
available data that allows for an appropriate comparison with 
the information reported in this study.
The Orthopedics and Traumatology Institute is a reference 
center for the treatment of high complexity trauma in the city 
of São Paulo, generally caused by traffic accidents. Most cases 
seen at our center are young patients with few co-morbidities. 
These characteristics differ substantially from those reported 
in other studies in the medical literature. This study shows 
a predominance of male patients in their third and fourth 
decade of life, with acute post-traumatic osteomyelitis of 
the lower limbs. The absence of hematogenic dissemination 
enhances the importance of the hospital setting and of 
high-energy traumas with open fractures as potential factors 
for the development of GNB osteomyelitis. 
The extended hospitalization time and the prolonged use 
of antimicrobials, both in inpatient and outpatient settings, 
show the high complexity associated with the treatment of 
these cases. Our results indicate a disease remission rate 
of about 60%, and a relapse rate of about 19%, although six 
months follow-up may be considered too short to evaluate 
the outcome of osteomyelitis treatment. No data from other 
studies are available to allow for an appropriate comparison 
of these outcomes, but a few authors report remission rates 
around 80% for Gram-positive infections and up to 20% 
relapse rate.2
A total of 121 agents have been isolated in cultures from 
101 patients. The most frequently isolated agents were 
Enterobacter sp., Acinetobacter baumannii and Pseudomonas 
aeruginosa representing about 70% of all the isolates. The 
susceptibility profile shows carbapenems with preserved 
activity against Enterobacter sp., yet with progressively reduced 
susceptibility to P. aeruginosa and A. baumannii.
Conclusion
GNB osteomyelitis constitutes an important therapeutic 
challenge, especially when associated to nonfermenting 
bacteria. These pathogens should be taken into account for 
the initial selection of antibiotics in osteomyelitis-confirmed 
cases, with view at optimizing antimicrobial regimen from the 
very beginning of the treatment. 
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